FIELD: pharmaceutics.
SUBSTANCE: invention relates to novel pyrazole derivatives of chemical formula I, where R, A and B are defined in the claim, stereoisomers or pharmaceutically acceptable salts thereof, and a pharmaceutical composition containing same for preventing, improving clinical course or treating diseases associated with oxidative stress.
EFFECT: novel pyrazole derivatives are disclosed.
9 cl, 8 dwg, 2 tbl, 73 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AMINOTRIAZOLOPYRIDINES AND USING THEM AS KINASE INHIBITORS | 2009 |
|
RU2552642C2 |
| SIGMA-RECEPTOR INHIBITORS | 2005 |
|
RU2404972C2 |
| BICYCLIC LACTAMS AND METHODS OF USE THEREOF | 2016 |
|
RU2827714C1 |
| mTOR KINASE INHIBITORS FOR ONCOLOGICAL INDICATIONS AND DISEASES METABOLICALLY BOUND TO mTOR/PI3K/AKT | 2009 |
|
RU2546658C2 |
| SERINE/THREONINE KINASE INHIBITORS | 2013 |
|
RU2650501C2 |
| NOVEL COMPOUNDS | 2015 |
|
RU2691389C2 |
| SPIRO CONDENSED PYRROLIDINE DERIVATIVES AS INHIBITORS OF DEUBIQUITINATING ENZYMES (DUB) | 2017 |
|
RU2730552C2 |
| COMPOUND HAVING KINASE INHIBITORY ACTIVITY | 2021 |
|
RU2831403C1 |
| PYRAZOLE DERIVATIVES APPLIED AS PROTEIN KINASE INHIBITORS | 2001 |
|
RU2340611C2 |
| CLASS OF CONDENSED RING COMPOUNDS AND THEIR PRODUCTION AND USE | 2021 |
|
RU2831125C1 |
